New Chinese 5-year plan promises 2.5% R&D:GDP ratio by 2020, up from 2.05% in 2014.

Proposed controls on foreign operations in China are a threat to scientific collaboration.

Rumours of germline modification prove true — and look set to reignite an ethical debate.

China has come to an unsettling conclusion: the system that it uses to invest in science and technology is broken.

Core science gets budget boost in a bid to change research culture and increase innovation.